Philip Astley-Sparke

Insider Reports History

Location
Woburn, MA
Signature
/s/ Lee Giguere, as attorney-in-fact for the Reporting Person
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Philip Astley-Sparke:

Company Role Class Num Shares Value Price $ Report Date Ownership
Replimune Group, Inc. Director Common Stock 1,405,071 $11,324,872 $8.06 20 May 2025 Direct
enGene Holdings Inc. Director Common Shares 20,000 $57,600 $2.88 08 Jul 2025 Direct
enGene Holdings Inc. Director Stock Option (Right to Buy) 45,000 08 Jul 2025 Direct

Insider Reports Filed by Philip Astley-Sparke

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ENGN enGene Holdings Inc. 08 Jul 2025 1 $0 4 Director 10 Jul 2025, 16:07
ENGN enGene Holdings Inc. 08 Jul 2025 0 $0 3 Director 08 Jul 2025, 16:11
REPL Replimune Group, Inc. 20 May 2025 1 -$260,169 4 Director 22 May 2025, 21:47
REPL Replimune Group, Inc. 30 Aug 2024 1 $0 4 Executive Chairman, Director 30 Aug 2024, 20:00
REPL Replimune Group, Inc. 16 May 2024 1 -$245,394 4 Executive Chairman, Director 20 May 2024, 20:04
REPL Replimune Group, Inc. 16 May 2023 1 -$323,131 4 Chief Executive Officer, Director 18 May 2023, 20:30
REPL Replimune Group, Inc. 01 Apr 2023 2 $0 4 Chief Executive Officer, Director 04 Apr 2023, 20:00
REPL Replimune Group, Inc. 16 May 2022 1 -$140,531 4 Chief Executive Officer, Director 18 May 2022, 19:00
REPL Replimune Group, Inc. 01 Apr 2022 2 $0 4 Chief Executive Officer, Director 05 Apr 2022, 16:18
/report/000095010321019579-astley-sparke-philip-2021-12-09 Forbion European Acquisition Corp. 09 Dec 2021 0 $0 3 Director 09 Dec 2021, 16:37